Induced pluripotent stem cells: a tool for modeling Parkinson's disease
Anindita Bose1, Gregory A Petsko1, Lorenz Studer2
1Ann Romney Institute of Neurological Diseases, Harvard Medical School/Brigham and Women's Hospital, Boston, MA, USA.
Trends in Neurosciences
|June 6, 2022
Summary
Induced pluripotent stem cell (iPSC) technology enables patient-derived models for Parkinson's disease (PD) research. Future models need to address aging and gene-environment interactions for a comprehensive understanding of PD.
Area of Science:
- Neurodegenerative disorders
- Stem cell biology
- Parkinson's disease research
Background:
- Parkinson's disease (PD) is the second leading neurodegenerative disorder.
- Characteristic pathology involves the loss of dopaminergic (DA) neurons in the substantia nigra.
- This neuronal loss contributes significantly to severe PD symptoms.
Purpose of the Study:
- To review the application of induced pluripotent stem cell (iPSC) technology in modeling Parkinson's disease.
- To highlight the utility of patient-derived DA neuronal cell cultures and organoids.
- To identify current limitations and future directions in PD modeling.
Main Methods:
- Utilizing induced pluripotent stem cell (iPSC) technology.
- Generating patient-derived dopaminergic (DA) neuronal cell cultures.
- Developing organoid models for Parkinson's disease (PD).
Main Results:
- iPSC technology facilitates the creation of patient-specific PD models.
- These models aid in understanding disease mechanisms.
- Novel therapeutic targets and candidates have been identified using these models.
Conclusions:
- Patient-derived iPSC models offer valuable insights into Parkinson's disease.
- Improved modeling is required for age-related PD aspects.
- Further research is needed to understand gene-gene and gene-environment interactions in PD etiology and progression.
More Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
01:13Induced Pluripotent Stem Cells
24.5K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.5K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K